問卷

TPIDB > Search Result

Search Result

篩選

List

2272Cases

2025-05-01 - 2027-11-30

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Recruiting6Sites

2022-02-28 - 2026-12-10

Phase I/II

Active
An Open Label, First-in-human Study of BAY 2927088 in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) Harboring an EGFR and/or HER2 Mutation
  • Condition/Disease

    Advanced Non-small Cell Lung Cancer、EGFR Mutation、HER2 Mutation

  • Test Drug

    BAY 2927088

Participate Sites
7Sites

Not yet recruiting2Sites

Recruiting2Sites

Terminated3Sites

2020-10-16 - 2028-06-26

Others

Active
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Recruiting6Sites

2020-03-15 - 2025-05-15

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2020-03-17 - 2024-05-02

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Not yet recruiting2Sites

Recruiting6Sites

2022-07-01 - 2025-03-14

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Terminated9Sites

2011-02-28 - 2012-02-28

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2025-03-31 - 2028-06-30

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
13Sites

Recruiting13Sites

2004-04-01 - 2006-12-01

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2006-03-01 - 2009-03-01

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated5Sites